Women trying to conceive face sharply lower odds of pregnancy when their blood carries elevated levels of chemicals found in nonstick cookware, food packaging, plastics, and personal-care products, according to multiple peer-reviewed cohort studies spanning Denmark, Canada, and Singapore. The strongest finding comes from a Singaporean preconception cohort, where a mixture of per- and polyfluoroalkyl substances (PFAS) was tied to roughly 39 percent lower odds of clinical pregnancy per quartile increase in exposure. Separate research on bisphenol A (BPA) found that women in the highest exposure quartile experienced about a 30 percent drop in fecundability, while phthalates common in fragrances and shampoos were linked to longer time to pregnancy for couples actively trying to conceive.
Falling birth rates collide with persistent chemical exposures
The fertility effects reported in these studies land at a moment when birth rates across high-income countries continue to decline and demand for assisted reproduction keeps rising. What makes the chemical exposure data especially relevant is the sheer ubiquity of the compounds involved. PFAS, often called “forever chemicals,” resist breakdown in the environment and in the human body. BPA lines food cans and thermal receipts. Phthalates show up in vinyl flooring, shower curtains, and scented products. Virtually every adult carries measurable levels of at least one of these substances.
The hypothesis that targeted removal of specific PFAS compounds from menstrual products and food packaging could produce a measurable 15 to 20 percent improvement in fecundability within 18 months is scientifically plausible but currently untested. No published preconception biomarker study has yet tracked fertility outcomes before and after a product-level intervention. The cohort data described below establish the association between exposure and reduced fertility, but the intervention side of that equation has no trial evidence behind it.
Cohort data linking PFAS, BPA, and phthalates to reduced fertility
The largest body of evidence centers on PFAS. In the Danish cohort, researchers measured early-pregnancy plasma concentrations of PFOS and PFOA and found that women in the highest PFOA quartile had elevated odds of infertility, defined as time to pregnancy exceeding 12 months. Fecundability odds ratios declined across higher exposure groups, meaning each step up in PFOA concentration corresponded with a longer expected wait to conceive.
Canadian data from the Maternal-Infant Research on Environmental Chemicals (MIREC) study reinforced that pattern. MIREC researchers reported a roughly 9 to 11 percent reduction in fecundability per standard-deviation increase in plasma PFOA and PFHxS. Those effect sizes are smaller than the Danish findings, but they emerged in a population with lower overall PFAS exposure, suggesting that even modest concentrations carry a measurable fertility cost.
The sharpest estimate comes from the S-PRESTO cohort in Singapore, which evaluated preconception plasma PFAS levels and clinical pregnancy outcomes. When researchers modeled the combined effect of multiple PFAS compounds as a mixture, they found an odds ratio of approximately 0.61 per quartile increase, translating to about 39 percent lower odds of achieving clinical pregnancy. That figure anchors the “up to 40 percent” framing and represents the upper bound of the fertility reduction documented so far.
Beyond PFAS, BPA exposure tells a parallel story. A preconception cohort study published in Environment International found that women in the highest BPA quartile had a fecundability odds ratio of roughly 0.70, equivalent to about a 30 percent reduction in the probability of conception per cycle compared with women in the lowest quartile. The investigators linked higher odds of subfertility to greater urinary concentrations of bisphenol A, underscoring how even short-lived consumer chemicals can influence the delicate hormonal balance needed for successful conception.
Phthalates add a third chemical class to the pattern. The NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development summarized peer-reviewed prospective data showing that phthalates were associated with longer time to pregnancy in couples trying to conceive. That research highlighted male partners’ plasticizer levels as a contributing factor, broadening the exposure concern beyond the woman’s own body burden and pointing to the couple as the relevant unit of analysis when evaluating environmental risks to fertility.
The MIREC study separately examined BPA, triclosan, and phthalate metabolites in relation to women’s time to pregnancy, adding Canadian cohort evidence that personal-care chemicals can independently affect fecundability. Women with higher urinary concentrations of these compounds tended to experience longer waits before conceiving, even after adjusting for age, smoking, and other confounders. While effect sizes varied by metabolite, the overall pattern was consistent with the PFAS and BPA findings: higher exposure corresponded with lower per-cycle probability of pregnancy.
Taken together, these cohorts do not prove causation, but they offer converging evidence across countries, chemical classes, and study designs. PFAS, BPA, and phthalates differ in structure and persistence, yet they all interact with endocrine pathways involved in ovulation, implantation, and early embryonic development. The repeated association between higher body burdens and reduced fecundability strengthens the case that these widely used products are not benign background exposures for people hoping to start a family.
What the numbers mean for couples and clinicians
For individual couples, a 30 to 40 percent reduction in fecundability does not mean pregnancy is impossible, but it does shift the odds over time. A healthy couple in their late 20s might expect roughly a 20 to 25 percent chance of conceiving in any given cycle. If exposures lower that probability by a third, the cumulative likelihood of conceiving within six or 12 months drops meaningfully, pushing more couples into the clinical definition of subfertility and toward fertility clinics.
Clinicians increasingly field questions about environmental chemicals from patients planning pregnancies. The current evidence base supports counseling that emphasizes precaution without guaranteeing benefit. Because randomized trials are lacking, no physician can promise that avoiding a specific product will improve a given patient’s chances. Yet the observational data justify recommending reasonable exposure reductions that carry little downside: limiting consumption of highly packaged foods, avoiding microwaving plastic containers, choosing fragrance-free personal-care items when possible, and reducing contact with thermal receipts.
For fertility specialists, these findings raise questions about how environmental histories should be integrated into routine assessment. Standard workups focus on age, ovulatory function, semen parameters, and structural factors such as tubal patency. Adding detailed exposure questionnaires or optional biomonitoring could help identify couples whose difficulty conceiving may be partly explained by preventable chemical burdens. However, without clear intervention trials, there is no consensus on how aggressively to pursue such testing or how to interpret marginal exposure differences in clinical practice.
Policy gaps and research priorities
On the policy front, the fertility data intersect with broader debates about chemical regulation. PFAS have already drawn regulatory scrutiny because of their persistence and links to cancer, immune dysfunction, and metabolic disease. The emerging reproductive evidence adds another rationale for phasing out nonessential uses, particularly in products that disproportionately affect people of reproductive age, such as menstrual supplies, cosmetics, and fast-food packaging.
For BPA and phthalates, regulators in several jurisdictions have restricted certain uses, especially in children’s products, but adult reproductive health has received less explicit attention. The cohort findings suggest that timing matters: exposures in the months before conception may be as important as exposures during pregnancy itself. Policies that focus only on fetal and infant protection may miss an opportunity to improve the chances of pregnancy for would-be parents who are already struggling.
Researchers, meanwhile, face a dual challenge. First, they must refine exposure assessment, capturing mixtures of chemicals rather than evaluating each in isolation. The Singapore PFAS mixture analysis illustrates how combined exposures can have stronger associations with outcomes than any single compound. Second, they need to move beyond observational cohorts toward intervention studies that test whether reducing specific exposures leads to measurable improvements in time to pregnancy or live birth rates.
Designing such trials will not be easy. Randomizing individuals to “high” versus “low” chemical exposure would be unethical in many cases. Instead, investigators are likely to rely on natural experiments, policy changes, or product reformulations that create before-and-after contrasts. For example, if a major manufacturer removes PFAS from a popular brand of food packaging, researchers could compare conception rates among frequent consumers before and after the change, while tracking biomarkers to confirm reduced body burdens.
Until those data arrive, the link between everyday chemicals and human fertility will remain probabilistic rather than definitive. Yet for couples who have already rearranged their lives around the hope of a child, the emerging science offers both a warning and a measure of agency. The warning is that the modern chemical environment may be quietly eroding the odds of pregnancy long before anyone seeks medical help. The agency lies in recognizing that some of these exposures are modifiable, and that personal choices, clinical guidance, and policy reforms can all play a role in nudging the odds back in favor of conception.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
